Gender, Brain-Derived Neurotrophic Factor Val66Met, and Frequency of Methamphetamine Use
- 1 April 2012
- journal article
- Published by Elsevier in Gender Medicine
- Vol. 9 (2) , 112-120
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The effects of progesterone pretreatment on the response to oral d-amphetamine in WomenHormones and Behavior, 2010
- Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependencePsychiatry Research, 2010
- Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?Hormones and Behavior, 2010
- Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependenceDrug and Alcohol Dependence, 2010
- Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependenceDrug and Alcohol Dependence, 2008
- (+)‐Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal ratsSynapse, 2007
- Similar discriminative-stimulus effects of d-amphetamine in women and menPharmacology Biochemistry and Behavior, 2007
- Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal womenPharmacology Biochemistry and Behavior, 2007
- Estrogen–BDNF interactions: Implications for neurodegenerative diseasesFrontiers in Neuroendocrinology, 2006
- An association study of the brain‐derived neurotrophic factor Val66Met polymorphism and amphetamine responseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006